• |
  • |
  • |
  • |
Donate

Project

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Brexpiprazole in Treatment of Children and Adolescents With Irritability

Center:
Fiscal Year:
2021
Contact Information:
Project Description:
To evaluate the efficacy, safety, and tolerability of brexpiprazole in reducing irritability in children and adolescents ages 5 to 17 years with a diagnosis of ASD.
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
State
Funding Source:
COVID-19 Related Data:
N/A